In STEP-1 (semaglutide), lean mass decreased by ~9.7% while fat mass fell by ~19.3%, with the proportion of lean mass increasing by ~3 percentage points ( Limited preclinical and clinical data, particularly from MRI-based studies, suggest that skeletal muscle changes induced by GLP-1RAs may be adaptive
Only in very limited circumstances, such as: BMI remains marginally above 22 kg/m Significant history of obesity-related disease Clear risk of rapid weight regain However: Treatment below BMI 22 kg/m is not routine Continuation is never guaranteed Each case is reviewed individually What Happens When You Stop GLP-1 Medication
How Formulation and Dosing Strategy Impact Side Effect Severity The same active medication delivered by different formulation routes produces different tolerability profiles
Pea protein can be made from genetically modified peas, so I always recommend choosing only organic pea protein
Think of glutathione as your bodys master antioxidant
Advances in bariatric surgery and weight-loss medications have made weight management accessible to more adults
